See more : Barinthus Biotherapeutics plc (BRNS) Income Statement Analysis – Financial Results
Complete financial analysis of Hogy Medical Co.,Ltd. (3593.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hogy Medical Co.,Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Concord Acquisition Corp II WT (CNDA-WT) Income Statement Analysis – Financial Results
- Nykredit Invest Balance Moderat (NBIMOKL.CO) Income Statement Analysis – Financial Results
- PAO Sovcomflot (FLOT.ME) Income Statement Analysis – Financial Results
- Renesas Electronics Corporation (RNECY) Income Statement Analysis – Financial Results
- BP p.l.c. (BPE5.DE) Income Statement Analysis – Financial Results
Hogy Medical Co.,Ltd. (3593.T)
About Hogy Medical Co.,Ltd.
Hogy Medical Co.,Ltd., together with its subsidiaries, manufactures and sells medical supplies to healthcare facilities in Japan. It offers kit products for surgery applications; all-in-one kits for pre/mid/post-surgery; non-woven products, including gowns, personal protective equipment and wearables, drapes, packaged products, instrument table covers, and wraps; and Tigalyer, a multi-layer fabric. The company also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and autoclave forceps stand caps; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, it offers ME equipment operation management system; narcotics/poisons box, an automatic drug reading management system using radio frequency identification; and Securea, a polyurethane sponge for endoscopic surgery. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co.,Ltd. in 1987. Hogy Medical Co.,Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 39.10B | 38.98B | 36.78B | 36.50B | 37.23B | 36.66B | 36.92B | 36.86B | 36.57B | 35.23B | 34.79B | 33.09B | 31.87B | 31.31B | 31.34B | 31.01B | 29.01B | 27.29B | 26.43B | 24.96B |
| Cost of Revenue | 26.61B | 23.24B | 21.36B | 21.18B | 21.80B | 21.83B | 22.45B | 20.36B | 18.98B | 17.86B | 17.05B | 16.38B | 15.71B | 14.83B | 15.14B | 15.47B | 14.09B | 13.49B | 12.86B | 12.23B |
| Gross Profit | 12.49B | 15.74B | 15.42B | 15.33B | 15.43B | 14.83B | 14.47B | 16.50B | 17.58B | 17.38B | 17.75B | 16.71B | 16.16B | 16.48B | 16.20B | 15.53B | 14.92B | 13.80B | 13.57B | 12.74B |
| Gross Profit Ratio | 31.95% | 40.38% | 41.92% | 41.99% | 41.45% | 40.45% | 39.19% | 44.78% | 48.09% | 49.32% | 51.01% | 50.50% | 50.71% | 52.64% | 51.68% | 50.10% | 51.42% | 50.57% | 51.35% | 51.02% |
| Research & Development | 297.00M | 379.00M | 444.00M | 677.00M | 607.00M | 789.00M | 430.00M | 485.00M | 403.00M | 508.00M | 620.00M | 542.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 7.23B | 7.32B | 7.41B | 7.71B | 7.99B | 8.41B | 7.34B | 6.61B | 6.41B | 7.00B | 7.18B | 6.02B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 1.09B | 1.12B | 1.06B | 1.08B | 1.06B | 1.04B | 986.00M | 962.00M | 946.00M | 923.00M | 894.00M | 1.26B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 8.03B | 8.44B | 8.48B | 8.79B | 9.06B | 9.45B | 8.32B | 7.57B | 7.35B | 7.92B | 8.08B | 7.27B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 31.00M | 132.00M | 285.00M | 324.00M | -10.00M | 53.00M | -70.00M | 42.00M | 88.00M | 134.00M | 73.00M | 106.00M | 127.00M | 134.00M | 167.85M | 73.88M | 70.62M | 32.22M | 44.86M |
| Operating Expenses | 8.32B | 9.11B | 9.28B | 9.69B | 10.13B | 10.44B | 9.19B | 9.06B | 8.80B | 8.87B | 9.00B | 8.60B | 8.41B | 7.88B | 8.22B | 8.03B | 7.68B | 7.75B | 7.37B | 7.01B |
| Cost & Expenses | 34.93B | 32.35B | 30.64B | 30.87B | 31.92B | 32.28B | 31.64B | 29.42B | 27.78B | 26.73B | 26.05B | 24.98B | 24.12B | 22.71B | 23.36B | 23.51B | 21.78B | 21.24B | 20.23B | 19.23B |
| Interest Income | 249.00M | 106.00M | 39.00M | 63.00M | 70.00M | 45.00M | 30.00M | 20.00M | 12.00M | 11.00M | 5.00M | 5.00M | 3.00M | 3.00M | 7.00M | 8.68M | 21.97M | 15.63M | 30.90M | 14.83M |
| Interest Expense | 23.00M | 29.00M | 6.00M | 2.00M | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.00M | 20.00M | 35.00M | 50.09M | 64.24M | 23.22M | 0.00 | 0.00 |
| Depreciation & Amortization | 6.61B | 3.62B | 4.12B | 4.55B | 5.28B | 5.63B | 6.24B | 4.41B | 3.38B | 2.71B | 2.87B | 2.97B | 3.06B | 2.28B | 2.46B | 2.91B | 2.71B | 2.91B | 2.32B | 2.24B |
| EBITDA | 10.71B | 10.25B | 10.25B | 10.18B | 10.59B | 10.01B | 11.51B | 11.85B | 12.16B | 11.21B | 11.61B | 11.32B | 10.89B | 9.77B | 10.70B | 8.96B | 9.60B | 9.04B | 8.76B | 8.05B |
| EBITDA Ratio | 27.38% | 26.78% | 28.34% | 29.04% | 29.79% | 16.49% | 25.35% | 29.41% | 33.56% | 32.13% | 33.87% | 33.50% | 34.18% | 34.67% | 33.55% | 34.14% | 34.69% | 33.26% | 32.19% | 32.25% |
| Operating Income | 4.17B | 6.63B | 6.14B | 5.63B | 5.31B | 4.38B | 5.27B | 7.44B | 8.78B | 8.51B | 8.75B | 8.11B | 7.75B | 8.60B | 7.97B | 7.50B | 7.23B | 6.06B | 6.20B | 5.73B |
| Operating Income Ratio | 10.66% | 17.02% | 16.68% | 15.43% | 14.25% | 11.95% | 14.28% | 20.19% | 24.02% | 24.14% | 25.14% | 24.52% | 24.32% | 27.47% | 25.44% | 24.19% | 24.93% | 22.20% | 23.46% | 22.96% |
| Total Other Income/Expenses | -94.00M | -445.00M | 151.00M | 1.36B | 2.42B | 4.12B | 2.31B | 979.00M | -41.00M | 173.00M | 138.00M | 240.00M | 72.00M | -1.13B | 129.00M | -1.51B | -407.12M | 44.05M | 245.82M | 83.17M |
| Income Before Tax | 4.08B | 6.19B | 6.29B | 6.99B | 7.73B | 8.50B | 7.58B | 8.42B | 8.74B | 8.68B | 8.89B | 8.35B | 7.82B | 7.48B | 8.10B | 6.00B | 6.83B | 6.10B | 6.45B | 5.81B |
| Income Before Tax Ratio | 10.42% | 15.88% | 17.09% | 19.15% | 20.75% | 23.18% | 20.54% | 22.85% | 23.91% | 24.63% | 25.54% | 25.24% | 24.54% | 23.87% | 25.86% | 19.34% | 23.53% | 22.36% | 24.39% | 23.29% |
| Income Tax Expense | 1.28B | 1.90B | 1.95B | 2.06B | 2.24B | 2.46B | 2.32B | 2.64B | 2.83B | 3.02B | 3.25B | 3.11B | 3.20B | 3.02B | 3.18B | 2.41B | 2.77B | 2.48B | 2.54B | 2.32B |
| Net Income | 2.80B | 4.32B | 4.37B | 4.96B | 5.53B | 6.04B | 5.26B | 5.79B | 5.91B | 5.66B | 5.63B | 5.25B | 4.62B | 4.45B | 4.92B | 3.58B | 4.05B | 3.62B | 3.91B | 3.49B |
| Net Income Ratio | 7.17% | 11.07% | 11.88% | 13.58% | 14.85% | 16.48% | 14.25% | 15.70% | 16.16% | 16.06% | 16.19% | 15.85% | 14.51% | 14.22% | 15.70% | 11.56% | 13.98% | 13.27% | 14.79% | 14.00% |
| EPS | 115.54 | 177.93 | 152.99 | 164.03 | 183.05 | 198.31 | 168.04 | 168.04 | 187.91 | 179.91 | 179.05 | 166.81 | 147.01 | 141.55 | 157.87 | 119.24 | 134.87 | 117.35 | 123.41 | 110.11 |
| EPS Diluted | 115.54 | 177.93 | 152.99 | 164.03 | 183.05 | 198.31 | 168.04 | 168.04 | 187.91 | 179.91 | 179.05 | 166.81 | 147.01 | 141.55 | 157.87 | 119.24 | 134.87 | 117.35 | 113.71 | 100.98 |
| Weighted Avg Shares Out | 24.27M | 24.26M | 28.56M | 30.23M | 30.20M | 30.47M | 31.31M | 31.36M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.17M | 30.06M | 30.07M | 30.86M | 31.14M | 31.13M |
| Weighted Avg Shares Out (Dil) | 24.27M | 24.26M | 28.56M | 30.23M | 30.20M | 30.47M | 31.31M | 31.36M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.46M | 31.17M | 30.06M | 30.07M | 30.86M | 34.38M | 34.61M |
Source: https://incomestatements.info
Category: Stock Reports